Back to Report Store Home

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

  • Published: Jan-2015
  • Report Code: GBIHC352MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Colorectal Cancer Therapeutics, Global, European Society for Medical Oncology Treatment Guidelines (Colorectal Cancer at Stage I to III)

Figure 2: Colorectal Cancer Therapeutics, Global, European Society for Medical Oncology Treatment Guidelines (Colorectal Cancer at Stage IV)

Figure 3: Colorectal Cancer Therapeutics, Global, Heat Map (Marketed Products)

Figure 4: Colorectal Cancer Therapeutics, Global, Pipeline by Stage of Development and Program Type, 2014

Figure 5: Colorectal Cancer Therapeutics, Global, Pipeline by Molecule Type and Stage of Development, 2014

Figure 6: Colorectal Cancer Therapeutics, Global, Pipeline by Mechanism of Action and Stage of Development, 2014

Figure 7: Colorectal Cancer Therapeutics, Global, Clinical Trial Failure Rate (%), 2014

Figure 8: Colorectal Cancer Therapeutics, Global, Clinical Trial Size, 2014

Figure 9: Colorectal Cancer Therapeutics, Global, Clinical Trial Duration (months), 2014

Figure 10: Colorectal Cancer Therapeutics, Global, Treatment Use Patterns (‘000) and Market Size ($bn), 2013–2020

Figure 11: Colorectal Cancer Therapeutics, US and Canada, Treatment Use Patterns (‘000), 2013–2020

Figure 12: Colorectal Cancer Therapeutics, US and Canada, Annual Cost of Therapy ($), 2013–2020

Figure 13: Colorectal Cancer Therapeutics, US and Canada, Market Size ($m), 2013–2020

Figure 14: Colorectal Cancer Therapeutics, Top Five European Markets, Treatment Use Patterns (‘000), 2013–2020

Figure 15: Colorectal Cancer Therapeutics, Top Five European Markets, Annual Cost of Therapy ($), 2013–2020

Figure 16: Colorectal Cancer Therapeutics, Top Five European Markets, Market Size ($m), 2013–2020

Figure 17: Colorectal Cancer Therapeutics, Japan, Treatment Use Pattern, 2013–2020

Figure 18: Colorectal Cancer Therapeutics, Japan, Annual Cost of Therapy, 2013–2020

Figure 19: Colorectal Cancer Therapeutics, Japan, Market Size ($m), 2013–2020

Figure 20: Colorectal Cancer Therapeutics, Global, Licensing Deals by Geography, 2006–2014

Figure 21: Colorectal Cancer Therapeutics, Global, Licensing Deals by Phase, Value, Mechanism of Action, 2006–2014

Figure 22: Colorectal Cancer Market, Global, Co-development Deals by Geography and by Value, 2006–2014

Figure 23: GBI Research Market Forecasting Model

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards